Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-002236
Filing Date
2025-04-01
Accepted
2025-04-01 21:07:12
Documents
1
Period of Report
2025-03-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3379
  Complete submission text file 0001641172-25-002236.txt   4898
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Issuer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4 RIDGE ROAD TUXEDO PARK NY 10987
Business Address
Farley Chele Chiavacci (Reporting) CIK: 0001908750 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41245 | Film No.: 25801719